Although GBM samples showed a trend of hypomethylation, there was no statistically significant difference in SMARCAL1 promoter methylation between tumor and normal groups (Fig. 4 G), indicating that other regulatory mechanisms might influence its expression in GBM.
← all excerpts
Pan-cancer analysis reveals SMARCAL1 expression is associated with immune cell infiltration and poor prognosis in various cancers.
1
—
—